MGNX
Macrogenics Inc

4,055
Mkt Cap
$94.89M
Volume
1.8M
52W High
$3.77
52W Low
$0.9896
PE Ratio
-1.24
MGNX Fundamentals
Price
$1.50
Prev Close
$1.60
Open
$1.58
50D MA
$1.66
Beta
1.42
Avg. Volume
789,693.22
EPS (Annual)
-$1.07
P/B
1.42
Rev/Employee
$439,771.26
Loading...
Loading...
News
all
press releases
MacroGenics (NASDAQ:MGNX) Issues Earnings Results, Beats Estimates By $0.75 EPS
MacroGenics (NASDAQ:MGNX - Get Free Report) released its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.27 earnings per share (EPS) for the quarter, topping the...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenics (MGNX) delivered earnings and revenue surprises of +156.25% and +157.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
After losing some value lately, a hammer chart pattern has been formed for MacroGenics (MGNX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks·6d ago
News Placeholder
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates
Stryker (SYK) delivered earnings and revenue surprises of +1.59% and +0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
MacroGenics (MGNX) delivered earnings and revenue surprises of +3.39% and +4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
OrganiGram (OGI) delivered earnings and revenue surprises of -200.00% and +5.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
SNDL Inc. (SNDL) Surpasses Q2 Earnings and Revenue Estimates
SNDL INC (SNDL) delivered earnings and revenue surprises of +125.00% and +6.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates
AtriCure (ATRC) delivered earnings and revenue surprises of +86.67% and +4.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies
Zacks·6mo ago
News Placeholder
4 Medical Product Stocks to Watch From a Challenging Industry
Zacks·6mo ago

Latest MGNX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.